Aptevo Therapeutics Inc.
Balance Sheet
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $9.8M | $14.5M | $21.6M | $21.1M | $9.4M | $2.1M | $8.7M | $7.8M |
| Accounts Receivable | — | — | — | — | — | — | — | — |
| Inventory | — | — | — | — | — | — | — | — |
| Total Current Assets | $10.8M | $16.0M | $23.1M | $22.6M | $11.1M | $3.6M | $10.7M | $10.0M |
| Property, Plant & Equipment | $236.0K | $268.0K | $303.0K | $384.0K | $432.0K | $482.0K | $543.0K | $614.0K |
| Goodwill | — | — | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | — | — | — | — | — | — |
| Total Assets | $14.5M | $19.9M | $27.2M | $27.0M | $15.6M | $8.3M | $15.6M | $15.1M |
| Liabilities | ||||||||
| Accounts Payable | $1.2M | $890.0K | $877.0K | — | — | — | $1.2M | — |
| Total Current Liabilities | $5.2M | $4.8M | $6.1M | $5.6M | $4.9M | $5.4M | $6.2M | $5.9M |
| Long-Term Debt | — | — | — | — | — | — | — | — |
| Total Liabilities | $8.5M | $8.3M | $9.8M | $9.6M | $9.1M | $9.8M | $10.8M | $10.7M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-288.3M | $-281.9M | $-275.1M | $-269.2M | $-260.2M | $-254.0M | $-247.6M | $-241.3M |
| Total Stockholders' Equity | $6.0M | $11.6M | $17.4M | $17.4M | $6.5M | $-1.5M | $4.8M | $4.4M |